Soleno Therapeutics (SLNO) Goodwill & Intangibles (2015 - 2026)

Soleno Therapeutics (SLNO) has 12 years of Goodwill & Intangibles data on file, last reported at $4.4 million in Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $4.4 million, down 30.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.4 million (down 30.77% YoY), and the FY2025 annual result was $4.9 million, down 28.57% from the prior year.
• Goodwill & Intangibles retreated to $4.4 million in Q1 2026 per SLNO's latest filing, from $4.9 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $12.2 million in Q1 2022 and troughed at $4.4 million in Q1 2026.
• A 5-year average of $8.3 million and a median of $8.3 million in 2024 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2022 and 2026: Goodwill & Intangibles fell 13.79% in 2022, then sank 30.77% in 2026.
• A 5-year view of Goodwill & Intangibles shows it stood at $10.7 million in 2022, then slipped by 18.18% to $8.7 million in 2023, then dropped by 22.22% to $6.8 million in 2024, then declined by 28.57% to $4.9 million in 2025, then fell by 10.02% to $4.4 million in 2026.
• Business Quant data shows SLNO's Goodwill & Intangibles at $4.4 million in Q1 2026, $4.9 million in Q4 2025, and $5.3 million in Q3 2025.